THYROID-INDUCED CARDIOVASCULAR DISEASES: MECHANISMS AND CLINICAL IMPLICATIONS

Authors

  • Nasridinova Gulnoza Fazliddin qizi Author
  • Turdiyev Shukhrat Berdiyevich Author

Abstract

Thyroid dysfunction significantly impacts cardiovascular health, with both hyperthyroidism and hypothyroidism contributing to arrhythmias, heart failure, and atherosclerosis. This article reviews the pathophysiological mechanisms linking thyroid disorders (e.g., Graves’ disease, Hashimoto’s thyroiditis) to cardiovascular complications, emphasizing the role of triiodothyronine (T3) and thyroxine (T4) in cardiac contractility, rhythm regulation, and vascular tone. Clinical manifestations, diagnostic approaches (TSH, ECG, echocardiography), and management strategies (antithyroid drugs, β-blockers, hormone replacement) are discussed. Early detection and interdisciplinary care are critical to mitigating cardiovascular risks.

References

1. Biondi, B., & Cooper, D. S. (2018). Subclinical hyperthyroidism. New England Journal of Medicine, 378(25), 2411-2419. https://doi.org/10.1056/NEJMcp1709318

2. Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017). Hypothyroidism. Lancet, 390(10101), 1550-1562. https://doi.org/10.1016/S0140-6736(17)30703-1

3. Dillmann, W. H. (2019). Cardiac function in thyroid disease: Clinical features and management considerations. Annals of Thyroid Research, 5(1), 1-6. https://doi.org/10.17352/atr.000014

4. Gärtner, R., Gasnier, B. C., Dietrich, J. W., Krebs, B., & Angstwurm, M. W. (2017). Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. Journal of Clinical Endocrinology & Metabolism, 87(4), 1687-1691. https://doi.org/10.1210/jcem.87.4.8421

5. Klein, I., & Danzi, S. (2016). Thyroid disease and the heart. Circulation, 116(15), 1725-1735. https://doi.org/10.1161/CIRCULATIONAHA.106.678326

6. Razvi, S., Jabbar, A., Pingitore, A., Danzi, S., Biondi, B., Klein, I., Peeters, R., Zaman, A., & Iervasi, G. (2018). Thyroid hormones and cardiovascular function and diseases. Journal of the American College of Cardiology, 71(16), 1781-1796. https://doi.org/10.1016/j.jacc.2018.02.045

7. Selmer, C., Olesen, J. B., Hansen, M. L., Lindhardsen, J., Olsen, A. M., Madsen, J. C., Faber, J., Hansen, P. R., Pedersen, O. D., & Torp-Pedersen, C. (2014). The spectrum of thyroid disease and risk of new onset atrial fibrillation: A large population cohort study. BMJ, 348, g2651. https://doi.org/10.1136/bmj.g2651

8. Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018). Global epidemiology of hyperthyroidism and hypothyroidism. Nature Reviews Endocrinology, 14(5), 301-316. https://doi.org/10.1038/nrendo.2018.18

9. World Health Organization. (2021). Cardiovascular diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

Downloads

Published

2025-05-07